Imagerie des récepteurs de neuropeptides pour le ciblage tumoral

Imagerie des récepteurs de neuropeptides pour le ciblage tumoral

Des récepteurs de neuropeptides peuvent être fortement exprimés à la surface descellules tumorales offrant ainsi l’opportunité de les visualiser en imagerie par Tomographie d'Emissionde Positons (TEP) grâce à des analogues radiomarqués au 68Ga, 64Cu ou au 18F, mais également desélectionner des...

Full description

Bibliographic Details
Main Author:	Morgat, Clément
Other Authors:	Bordeaux
Language:	fr
Published:	2015
Subjects:	68Ga Neuropeptide Cancer Imagerie moléculaire Molecular imaging
Online Access:	http://www.theses.fr/2015BORD0308/document

Similar Items

Otto: a 4.04 GBq (109 mCi) 68Ge/68Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [68Ga]Ga-PSMA-11
by: Nicole N. Waterhouse, et al.
Published: (2020-02-01)

Desenvolvimento de métodos de purificação do Gálio-67 e Gálio-68 para a marcação de biomolécula
by: Renata Ferreira Costa
Published: (2012)

Desenvolvimento de métodos de purificação do Gálio-67 e Gálio-68 para a marcação de biomolécula
by: Costa, Renata Ferreira
Published: (2012)

Preparation and Quality Control of 68Ga-Citrate for PET Applications
by: Ayuob Aghanejad, et al.
Published: (2015-07-01)

Estudo de materiais adsorvedores para o preparo de geradores de Ge-68/Ga-68
by: Tânia de Paula Brambilla
Published: (2013)

Estudo de materiais adsorvedores para o preparo de geradores de Ge-68/Ga-68
by: Brambilla, Tânia de Paula
Published: (2013)

Analogues peptidiques marqués au gallium-68 pour l’imagerie TEP des récepteurs membranaires couplés aux protéines G
by: Prignon, Aurelie
Published: (2017)

Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
by: Thomas Ebenhan, et al.
Published: (2015-08-01)

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT
by: M. I. Ross, et al.
Published: (2020-09-01)

68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls
by: Zohar Keidar, et al.
Published: (2018-11-01)

[68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study
by: Sebastian Hoberück, et al.
Published: (2020-11-01)

The diagnostic value of PET/CT imaging with the 68Ga-labeled PSMA-ligand in the follow up assessment of prostate cancer after therapy
by: Talaat Ahmed Abd El Hameed Hassan, et al.
Published: (2020-07-01)

68Ga-NOTA-Evans Blue PET/CT findings in lymphangioleiomyomatosis compared with 99mTC-ASC lymphoscintigraphy: a prospective study
by: Guozhu Hou, et al.
Published: (2021-06-01)

Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agent for Colon Cancer
by: Radu Anton Leonte, et al.
Published: (2021-04-01)

[68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?
by: Jonathan Kuten, et al.
Published: (2019-08-01)

Neuropeptide S: a new neuropeptide that regulates sleep and wake
by: Zheng-qing ZHAO, et al.
Published: (2013-05-01)

Regulation of Feeding and Metabolism by Neuropeptide F and Short Neuropeptide F in Invertebrates
by: Melissa Fadda, et al.
Published: (2019-02-01)

Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
by: Felipe de Galiza Barbosa, et al.
Published: (2020-03-01)

<sup>68</sup>Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [<sup>68</sup>Ga]Ga-RM2
by: Adrien Chastel, et al.
Published: (2021-07-01)

Editorial: The Evolution of Neuropeptides - a Stroll Through the Animal Kingdom: Updates From the Ottawa 2019 ICCPB Symposium and Beyond
by: Klaus H. Hoffmann, et al.
Published: (2020-07-01)

Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
by: Jing Zhao, et al.
Published: (2020-12-01)

Preclinical Assessment Addressing Intravenous Administration of a [<sup>68</sup>Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
by: Vusani Mandiwana, et al.
Published: (2021-04-01)

Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer
by: Ameya D Puranik, et al.
Published: (2021-07-01)

The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
by: Alain Couvineau, et al.
Published: (2018-09-01)

Neuropeptide-induced modulation of carcinogenesis in a metastatic breast cancer cell line (MDA-MB-231LUC+)
by: Silvia Gutierrez, et al.
Published: (2018-12-01)

68Gallium-prostate-specific membrane antigen ligand positron-emission tomography or computed tomography in biochemical failure after radical prostatectomy: A case report
by: Irene A. Chidothe, et al.
Published: (2017-04-01)

Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer.
by: Batool Albalooshi, et al.
Published: (2020-01-01)

Preparation of Ga/Ni Solid Target for Cyclotron-Produced 68Ge by Electrodeposition
by: SHEN Yi-jia1,2;FU Hong-yu1;LUO Wen-bo1;DENG Xue-song1;LIU Yu-ping1;LI Guang1;XU Hong-wei1,2;WANG Gang1
Published: (2014-02-01)

Development and evaluation of a rapid analysis for HEPES determination in 68Ga-radiotracers
by: Sarah Pfaff, et al.
Published: (2018-10-01)

GMP-compliant production of [68Ga]Ga-NeoB for positron emission tomography imaging of patients with gastrointestinal stromal tumor
by: Marc Pretze, et al.
Published: (2021-07-01)

Preclinical Studies of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs
by: mojdeh naderi, et al.
Published: (2016-01-01)

Preparation and biological studies of 68Ga-DOTA-alendronate
by: Ashraf Fakhari, et al.
Published: (2016-07-01)

Optimization of injected 68Ga-PSMA activity based on list-mode phantom data and clinical validation
by: J. Wielaard, et al.
Published: (2020-04-01)

68Ga DOTATATE Uptake in Hemangioma Simulating Metastasis on PET Imaging
by: Bart Vertenten, et al.
Published: (2019-06-01)

Multimodality molecular imaging of the alveolar-capillary barrier in lung disease using albumin based optical and PET tracers
by: Andrei Molotkov, et al.
Published: (2020-12-01)

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
by: Nat P. Lenzo, et al.
Published: (2018-02-01)

Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
by: Junhao Wu, et al.
Published: (2021-09-01)

One-year experience with 68Ga-PSMA PET/CT: applications and results in biochemical recurrence of prostate cancer
by: Luciano Monteiro Prado Júnior, et al.
Published: (2018-05-01)

Production of the positron-emitting radionuclide 68Ga: the radiochemical scheme of radionuclide generator 68Ge → 68Ga
by: Ayagoz Y. Baimukhanova, et al.
Published: (2018-06-01)

Application of the 68Ge/68Ga Generator in Clinic
by: HUANG Qian-huan1;PAN Dong-hui2;XU Yu-ping2;SHENG Jie1;WANG Yan-ting2;YANG Min1,2
Published: (2017-04-01)